A detailed history of Cobblestone Capital Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cobblestone Capital Advisors LLC holds 11,078 shares of ABBV stock, worth $2.26 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
11,078
Previous 11,176 0.88%
Holding current value
$2.26 Million
Previous $2.04 Million 6.63%
% of portfolio
0.12%
Previous 0.13%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$154.79 - $180.76 $15,169 - $17,714
-98 Reduced 0.88%
11,078 $1.9 Million
Q1 2024

May 03, 2024

BUY
$159.82 - $182.1 $61,850 - $70,472
387 Added 3.59%
11,176 $2.04 Million
Q3 2023

Nov 07, 2023

SELL
$133.59 - $154.65 $28,187 - $32,631
-211 Reduced 1.92%
10,789 $1.61 Million
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $1.07 Million - $1.24 Million
-7,427 Reduced 40.3%
11,000 $1.75 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $294,738 - $353,468
2,131 Added 13.08%
18,427 $2.98 Million
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $1,744 - $2,001
13 Added 0.08%
16,296 $2.19 Million
Q2 2022

Aug 11, 2022

BUY
$137.62 - $174.96 $417,814 - $531,178
3,036 Added 22.92%
16,283 $2.49 Million
Q1 2022

Apr 29, 2022

SELL
$131.98 - $163.75 $3,167 - $3,930
-24 Reduced 0.18%
13,247 $2.15 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $2,148 - $2,718
-20 Reduced 0.15%
13,271 $1.8 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $46,284 - $52,539
-435 Reduced 3.17%
13,291 $1.43 Million
Q2 2021

Aug 05, 2021

SELL
$105.21 - $117.21 $52,710 - $58,722
-501 Reduced 3.52%
13,726 $1.55 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $71,712 - $78,946
-701 Reduced 4.7%
14,227 $1.54 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $6,439 - $8,693
80 Added 0.54%
14,928 $1.6 Million
Q3 2020

Nov 05, 2020

SELL
$85.91 - $100.83 $3,436 - $4,033
-40 Reduced 0.27%
14,848 $1.3 Million
Q2 2020

Aug 11, 2020

SELL
$73.37 - $98.18 $22,964 - $30,730
-313 Reduced 2.06%
14,888 $1.46 Million
Q4 2019

Feb 07, 2020

SELL
$72.13 - $90.25 $42,556 - $53,247
-590 Reduced 3.74%
15,201 $1.35 Million
Q3 2019

Nov 08, 2019

SELL
$62.98 - $75.72 $122,811 - $147,654
-1,950 Reduced 10.99%
15,791 $1.2 Million
Q2 2019

Jul 29, 2019

SELL
$65.7 - $83.98 $11,169 - $14,276
-170 Reduced 0.95%
17,741 $1.29 Million
Q1 2019

Apr 30, 2019

SELL
$77.14 - $90.79 $18,513 - $21,789
-240 Reduced 1.32%
17,911 $1.44 Million
Q4 2018

Jan 30, 2019

BUY
$77.85 - $96.01 $44,530 - $54,917
572 Added 3.25%
18,151 $1.67 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $38,142 - $42,402
-429 Reduced 2.38%
17,579 $0
Q2 2018

Aug 03, 2018

BUY
$89.78 - $106.23 $175,340 - $207,467
1,953 Added 12.16%
18,008 $0
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $20,242 - $27,106
-220 Reduced 1.35%
16,055 $1.52 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $16,568 - $18,168
-185 Reduced 1.12%
16,275 $1.57 Million
Q3 2017

Nov 06, 2017

BUY
$69.85 - $89.22 $1.15 Million - $1.47 Million
16,460
16,460 $1.46 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cobblestone Capital Advisors LLC Portfolio

Follow Cobblestone Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cobblestone Capital Advisors LLC , based on Form 13F filings with the SEC.

News

Stay updated on Cobblestone Capital Advisors LLC with notifications on news.